June 4, 2025 - 08:18

National security analyst Brett Velicovich has raised urgent concerns regarding the United States' defense capabilities, emphasizing that the nation is lagging significantly behind other countries in drone technology. During a recent appearance on a news program, Velicovich highlighted the necessity for the U.S. military to adapt its strategies and technologies to meet the demands of modern warfare, particularly in light of recent drone strikes in Ukraine.
Velicovich pointed out that the rapid advancements in drone technology by adversaries pose a serious threat to U.S. national security. He argued that the current state of American defense systems is "lightyears behind" those of other nations, which could undermine the effectiveness of U.S. military operations. The analyst stressed that the U.S. must invest in innovative technologies and rethink its approach to aerial combat to ensure it remains competitive on the global stage.
As drone warfare continues to evolve, Velicovich's warnings serve as a critical reminder of the need for the U.S. to prioritize modernization efforts in its defense strategy.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...